Skip to main content
FSCDR Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestream Session
Livestream Session
Meal
Meal
On Demand
On Demand
Back

Andrew D. Campbell, MD (he/him/his)

Director, Comprehensive Sickle Cell Center
Children’s National Hospital, George Washington University
George Washington University School of Medicine and Health Sciences
washington, District of Columbia, United States

A graduate of Morehouse College and Case Western Reserve School of Medicine. He completed his pediatric residency training at the Harvard affiliated Massachusetts General Hospital; this was followed by a Pediatric Hematology/Oncology Fellowship at Northwestern University - Lurie’s Children’s Hospital. Currently, he is the Director of the Comprehensive Sickle Cell Disease (SCD) Program at Children’s National Hospital (CNH) in Washington, DC, the one of the largest SCD Program in the country. Dr. Campbell is an Associate Professor of Pediatrics at George Washington University, Washington, DC and a Faculty Affiliate at the George Mason University, Manassas, Virginia. Prior to his role at CNH, he directed the University of Michigan Comprehensive Pediatric Hemoglobinopathies Program. As an international expert, he has lectured regionally, nationally, and globally on issues related to the care and healthcare system approach to patients and families dealing with the effects of SCD. He was an invited speaker at the September 2023 Science Summit at the United Nations General Assembly (UNGA) on Sickle Cell Disease: Gene Therapy to Improve Health and Cure Disease. He has served on the Steering Committee for the The Annual Scientific Conference on Sickle Cell and Thalassaemia (ASCAT) in London for the past 4 years. Dr. Campbell is currently the Principal Investigator of the American Society of Hematology Research Collaborative, “Washington DC, Maryland, Virginia (DMV) Sickle Cell Clinical Trials Network”. For the past several years he has focused his research on the clinical complexity of Sickle Cell Disease (SCD) in different populations through a multinational international consortium (CASiRe - Consortium for the Advancement of Sickle Cell Disease Research) which he directs including participants from Ghana, Italy, United Kingdom, and the United States. Other international work includes being a member of the Sickle in Africa Research Consortia, where he serves as a contributor to the SCD Ontology working group.

Disclosure information not submitted.

Presentation(s):